Evaluation of vitamin D levels in young patients with primary hyperparathyroidism combined with thyroid pathology
https://doi.org/10.52888/0514-2515-2024-363-4-70-75
Abstract
Aim. To assess vitamin D levels in young patients with primary hyperparathyroidism (PHPT) combined with thyroid gland pathology.
Materials and methods. A total of 48 patients with PHPT were studied from September 2021 to December 2023. The patients were divided into two groups: those with PHPT and those with primary hyperparathyroidism combined with thyroid pathology. Blood levels of parathyroid hormone (PTH), calcium, phosphorus, vitamin D, thyroid-stimulating hormone (TSH) and free thyroxine were measured. In addition, ultrasound and scintigraphy of the parathyroid and thyroid glands were performed.
Results and discussion. . Patients with PHPT and thyroid pathology had lower calcium levels (2.49±0.07 mmol/L) and higher vitamin D levels (19.1±2.9 ng/mL) than patients with PHPT alone (2.71±0.1 mmol/L and 10.6±1.5 ng/ mL, respectively). These differences may be related to the compensatory function of the body in the presence of both conditions. Ultrasound showed differences in the degree of parathyroid hyperplasia between the two groups.
Conclusion. Monitoring vitamin D and calcium levels is essential to accurately assess the condition of patients with PHPT, especially when combined with thyroid pathology. This will help to plan comprehensive treatment and reduce the risk of complications.
About the Authors
N. F. Niyazova
SEI “Aicenna Tajik State Medical University”
Tajikistan
Tajikistan
Niyazova Nargis Fazlihudoevna - Candidate of Medical Sciences, Associate Professor, Head of the Endocrinology Department
Tel: +992883309999
Dushanbe
S. B. Tursunova
SEI “Aicenna Tajik State Medical University”
Tajikistan
Tajikistan
Dushanbe
References
1. Vetshev P.S., Zhivotov V.A., Ablitsov A.Yu. Sochetanie mnogouzlovogo toksicheskogo zoba i pervichnogo giperparatireoza s redkoy ektopiey paratireomy [Combination of multinodular toxic goiter and primary hyperparathyroidism with rare ectopic parathyroidism]. Khirurgiya. Zhurnal imeni N.I. Pirogova - Pirogov Russian Journal of Surgery, 2020, No. 1, pp. 89-93. DOI: https:// doi.org/10.17116/hirurgia202001189.
2. Dedov I.I., Melnichenko G.A., Mokrysheva N.G. Pervichnyy giperparatireoz: klinika, diagnostika, differen-tsialnaya diagnostika, metody lecheniya [Primary hyperparathyroidism: clinic, diagnosis, differential diagnosis, treatment methods]. Problemy endokrinologii – Problems of Endocrinology, 2016, Vol. 62, No. 6, pp. 40-77. DOI:10.14341/probl201662640-77.
3. Maganeva I.S., Pigarova E.A., Shulpekova N.V. Otsenka fosforno-kaltsievogo obmena i metabolitov vitamina D u patsientov s pervichnym giperparatireozom na fone bolyusnoy terapii kolekaltsiferolom [Evaluation of phosphorus-calcium metabolism and vitamin D metabolites in patients with primary hyperparathyroidism on the background of bolus therapy with colecalciferol]. Problemy endokrinologii – Problems of Endocrinology, 2021, Vol. 67, No. 6, pp. 68-79. DOI: https://doi.org/10.14341/probl12851.
4. Mokrysheva N.G., Eremkina A.K., Mirnaya S.S. Klinicheskie rekomendatsii po pervichnomu giperparati-reozu, kratkaya versiya [Clinical guidelines for primary hyperparathyroidism, brief version]. Problemy endokrinologii – Problems of Endocrinology, 2021, Vol. 67, No. 4, pp. 94-124. DOI: https://doi.org/10.14341/probl12801.
5. Prokofeva N.A., Makarov I.V., Galkin R.A. Usovershenstvovanie diagnostiki pervichnogo giperparatireoza [Improving the diagnosis of primary hyperparathyroidism]. Tavricheskiy Mediko-Biologicheskiy Vestnik, 2021, Vol. 24, No 2, pp. 104-108. DOI: https://doi.org/10.37279/20708092-2021-24-2-104-108.
6. Runova G.E., Golounina O.O., Glinkina I.V., Fadeev V.V. Pervichnyy giperparatireoz i defitsit vitamina D [Primary hyperparathyroidism and vitamin D deficiency]. Terapevticheskii arkhiv, 2021, Vol. 93, No 10, pp. 1221-1226. DOI: https://doi.org/10.26442/00403660.2021.10.201081.
7. Suplotova L.A., Avdeeva V.A., Sudnitsyna A.S., Rozhinskaya L.Ya. Giperparatireoz i vitamin D: slozhnosti vzaimootnosheniy [Hyperparathyroidism and vitamin D: the complexities of the relationship]. Osteoporoz i osteopatii - Osteoporosis and Bone Diseases, 2022, Vol. 25, No. 1, pp. 23-28. DOI: https://doi.org/10.14341/osteo12944.
8. Battista C., Guarnieri V., Carnevale V. Vitamin D status in primary hyperparathyroidism: effect of genetic background. Endocrine, 2017, No. 55 (1), pp. 266-272. DOI: https://doi.org/10.1007/s12020-016-0974-x.
9. Bilezikian J.P., Khan A.A., Potts J.T. Jr.; Third International Workshop on the Management of Asymptomatic Primary Hyperthyroidism. Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the third international workshop. Journal of Clinical Endocrinology and Metabolism, 2009, No. 94 (2), pp. 335-339. DOI:10.1210/jc.2008-1763.
10. Pokhrel B., Leslie S.W., Levine S.N. Primary Hyperparathyroidism. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing, 2024.
11. Masliza H., Hanuni M., Ali T.S., Salwani T. Comparison of Vitamin D Levels, Bone Metabolic Marker Levels, and Bone Mineral Density among Patients with Thyroid Disease: A Cross-Sectional Study. Diagnostics, 2020, No. 10 (12), pp. 1075. DOI: 10.3390/diagnostics10121075.
Review
For citations:
Niyazova N.F., Tursunova S.B. Evaluation of vitamin D levels in young patients with primary hyperparathyroidism combined with thyroid pathology. Health care of Tajikistan. 2024;(4):70-75. (In Russ.) https://doi.org/10.52888/0514-2515-2024-363-4-70-75
Views:
140
Email this article 